Search research articles
Contact Us
Filters
Showing results (51-60 of 134) with videos related to
Page
of 14
Sort By:
Cancer Research
|
March 9, 2005
Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo
Luis Sanchez-Perez, Timothy Kottke, Rosa Maria Diaz, et al.
Journal for Immunotherapy of Cancer
|
March 12, 2021
Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model
Tereza Andreou, Jennifer Williams, Rebecca J Brownlie, et al.
Frontiers in Immunology
|
November 4, 2021
Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade
Elizabeth Appleton, Jehanne Hassan, Charleen Chan Wah Hak, et al.
Nature Cell Biology
|
June 3, 2020
STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy
Esther N Arwert, Emma L Milford, Antonio Rullan, et al.
Nature Cell Biology
|
June 20, 2020
Author Correction: STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy
Esther N Arwert, Emma L Milford, Antonio Rullan, et al.
Cancer Treatment Reviews
|
May 2, 2024
Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectives
Pablo Jiménez-Labaig, Antonio Rullan, Irene Braña, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 2, 2018
Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8<sup>+</sup> T cell trafficking
David Taggart, Tereza Andreou, Karen J Scott, et al.
Neuro-Oncology Advances
|
July 13, 2022
Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors
Matthew R Schuelke, Justin H Gundelach, Matt Coffey, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 22, 2008
Reovirus activates human dendritic cells to promote innate antitumor immunity
Fiona Errington, Lynette Steele, Robin Prestwich, et al.
BMC Cancer
|
June 8, 2011
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
Lucy Heinemann, Guy R Simpson, Angela Boxall, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 134) with videos related to
Sort By:
Page
of 14
Cancer Research
|
March 9, 2005
Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo
Luis Sanchez-Perez, Timothy Kottke, Rosa Maria Diaz, et al.
Journal for Immunotherapy of Cancer
|
March 12, 2021
Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model
Tereza Andreou, Jennifer Williams, Rebecca J Brownlie, et al.
Frontiers in Immunology
|
November 4, 2021
Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade
Elizabeth Appleton, Jehanne Hassan, Charleen Chan Wah Hak, et al.
Nature Cell Biology
|
June 3, 2020
STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy
Esther N Arwert, Emma L Milford, Antonio Rullan, et al.
Nature Cell Biology
|
June 20, 2020
Author Correction: STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy
Esther N Arwert, Emma L Milford, Antonio Rullan, et al.
Cancer Treatment Reviews
|
May 2, 2024
Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectives
Pablo Jiménez-Labaig, Antonio Rullan, Irene Braña, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 2, 2018
Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8<sup>+</sup> T cell trafficking
David Taggart, Tereza Andreou, Karen J Scott, et al.
Neuro-Oncology Advances
|
July 13, 2022
Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors
Matthew R Schuelke, Justin H Gundelach, Matt Coffey, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 22, 2008
Reovirus activates human dendritic cells to promote innate antitumor immunity
Fiona Errington, Lynette Steele, Robin Prestwich, et al.
BMC Cancer
|
June 8, 2011
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
Lucy Heinemann, Guy R Simpson, Angela Boxall, et al.
Page
of 14